UK pharma major GSK yesterday announced that the US Food and Drug Administration (FDA) has approved Exdensur ...

USA and Europe listed biotech PureTech has appointed Robert Lyne as chief executive (CEO), and as a member of the board of ...

US biotech Incyte yesterday revealed that the European Commission (EC) has approved Minjuvi (tafasitamab) in combination with ...

US venture firm MBX Capital has crossed $100 million in cumulative capital commitments to invest in early-stage biotech and ...

Switzerland-based Topadur Pharma, a biotech company developing innovative therapies for vascular regeneration, has announced ...

German biotech T-CURX today announced the first closing of a $20 million (17.7 million) Series A financing with a syndicate ...

US drug distribution and services group Cencora (NYSE: COR) said it has agreed to accelerate its acquisition of a controlling ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted a new indication for Dutch immunology company ...

US biotech Nektar Therapeutics shares increased by 10% in pre-market trading following promising Phase IIb trial results.

US clinical-stage oncology company NanOlogy has appointed David Arthur as chief executive, as it accelerates development of ...

Canadian biotech Oncolytics Biotech (Nasdaq: ONCY) has reported encouraging clinical and translational data for its oncolytic ...

Across major agencies, the past fortnight brought a steady cadence of regulatory decisions, committee opinions, and ...